Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.85 - $1.41 $9,017 - $14,958
10,609 New
10,609 $10,000
Q1 2022

May 16, 2022

SELL
$1.16 - $2.5 $115,375 - $248,655
-99,462 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$2.46 - $8.74 $244,676 - $869,297
99,462 New
99,462 $245,000
Q3 2021

Nov 15, 2021

SELL
$5.1 - $9.39 $178,500 - $328,650
-35,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$3.95 - $6.88 $138,250 - $240,800
35,000 New
35,000 $224,000
Q4 2020

Feb 16, 2021

SELL
$1.73 - $2.13 $50,626 - $62,332
-29,264 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$1.76 - $2.17 $33,065 - $40,767
18,787 Added 179.32%
29,264 $52,000
Q2 2020

Aug 14, 2020

BUY
$1.75 - $2.65 $18,334 - $27,764
10,477 New
10,477 $22,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $112M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.